Therapeutic Innovation: ATHRICINE Platform
Addressing Global Healthcare Challenges
The Cardiovascular Crisis:
19 Million Deaths
USD 146.5 billion Global cardio-therapeutics
80%
Residual risk despite current treatments
Our Solution: ATHRICINE Platform
It is a platform with:
Revolutionary drug delivery system
Enhanced therapeutic efficacy
Reduced side effects
Precise targeting capabilities
Cost-effective treatment approach
Manufacturing Excellence
Our advanced synthesis process ensures:
Consistent quality
Batch-to-batch reliability
Scalable production
Cost-effective manufacturing
Environmental sustainability
Safety and Biocompatibility
FTB-728 is designed with safety in mind:
Non-toxic components
Biodegradable structure
Minimal immune response
Controlled elimination
Environmental friendliness